▶ 調査レポート

世界の多血小板血漿療法市場規模・現状・予測（2021年-2027年）
• 英文タイトル：Global Platelet-rich Plasma Therapy Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の多血小板血漿療法市場規模・現状・予測（2021年-2027年） / Global Platelet-rich Plasma Therapy Market Size, Status and Forecast 2021-2027 / QFJ1-5954資料のイメージです。• レポートコード：QFJ1-5954
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Multi User￥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
QYResearch社発行の本調査レポートでは、多血小板血漿療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（純PRP、白血球豊富型PRP、白血球豊富型フィブリン（L-PRF））、用途別市場規模（整形外科、皮膚科、心筋損傷、歯科、神経損傷、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・多血小板血漿療法の市場動向
・企業の競争状況、市場シェア
・多血小板血漿療法の種類別市場規模と予測2016-2027（純PRP、白血球豊富型PRP、白血球豊富型フィブリン（L-PRF））
・多血小板血漿療法の用途別市場規模と予測2016-2027（整形外科、皮膚科、心筋損傷、歯科、神経損傷、その他）
・多血小板血漿療法の北米市場規模2016-2027（アメリカ、カナダ）
・多血小板血漿療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・多血小板血漿療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多血小板血漿療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・多血小板血漿療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Terumo、Arthrex、Zimmer Biomet、DePuy Synthes、EmCyte、Regen Lab、ISTO Biologics、Cesca Therapeutics、Weigao、REV-MED、Nuo Therapeutics）
・結論

Platelet-rich plasma (PRP) is a biological therapy that uses the patient’s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.

Market Analysis and Insights: Global Platelet-rich Plasma Therapy Market
The global Platelet-rich Plasma Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Platelet-rich Plasma Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Platelet-rich Plasma Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Platelet-rich Plasma Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Platelet-rich Plasma Therapy market.

Global Platelet-rich Plasma Therapy Scope and Market Size
Platelet-rich Plasma Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Platelet-rich Plasma Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)

Segment by Application
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Platelet-rich Plasma Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pure PRP
1.2.3 Leucocyte-rich PRP
1.2.4 Leukocyte-rich Fibrin (L-PRF)
1.3 Market by Application
1.3.1 Global Platelet-rich Plasma Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Orthopedic
1.3.3 Darmatology
1.3.4 Cardiac Muscle Injury
1.3.5 Dental
1.3.6 Nerve Injury
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Platelet-rich Plasma Therapy Market Perspective (2016-2027)
2.2 Platelet-rich Plasma Therapy Growth Trends by Regions
2.2.1 Platelet-rich Plasma Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Platelet-rich Plasma Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Platelet-rich Plasma Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Platelet-rich Plasma Therapy Industry Dynamic
2.3.1 Platelet-rich Plasma Therapy Market Trends
2.3.2 Platelet-rich Plasma Therapy Market Drivers
2.3.3 Platelet-rich Plasma Therapy Market Challenges
2.3.4 Platelet-rich Plasma Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Platelet-rich Plasma Therapy Players by Revenue
3.1.1 Global Top Platelet-rich Plasma Therapy Players by Revenue (2016-2021)
3.1.2 Global Platelet-rich Plasma Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Platelet-rich Plasma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Platelet-rich Plasma Therapy Revenue
3.4 Global Platelet-rich Plasma Therapy Market Concentration Ratio
3.4.1 Global Platelet-rich Plasma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Platelet-rich Plasma Therapy Revenue in 2020
3.5 Platelet-rich Plasma Therapy Key Players Head office and Area Served
3.6 Key Players Platelet-rich Plasma Therapy Product Solution and Service
3.7 Date of Enter into Platelet-rich Plasma Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Platelet-rich Plasma Therapy Breakdown Data by Type
4.1 Global Platelet-rich Plasma Therapy Historic Market Size by Type (2016-2021)
4.2 Global Platelet-rich Plasma Therapy Forecasted Market Size by Type (2022-2027)

5 Platelet-rich Plasma Therapy Breakdown Data by Application
5.1 Global Platelet-rich Plasma Therapy Historic Market Size by Application (2016-2021)
5.2 Global Platelet-rich Plasma Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Platelet-rich Plasma Therapy Market Size (2016-2027)
6.2 North America Platelet-rich Plasma Therapy Market Size by Type
6.2.1 North America Platelet-rich Plasma Therapy Market Size by Type (2016-2021)
6.2.2 North America Platelet-rich Plasma Therapy Market Size by Type (2022-2027)
6.2.3 North America Platelet-rich Plasma Therapy Market Size by Type (2016-2027)
6.3 North America Platelet-rich Plasma Therapy Market Size by Application
6.3.1 North America Platelet-rich Plasma Therapy Market Size by Application (2016-2021)
6.3.2 North America Platelet-rich Plasma Therapy Market Size by Application (2022-2027)
6.3.3 North America Platelet-rich Plasma Therapy Market Size by Application (2016-2027)
6.4 North America Platelet-rich Plasma Therapy Market Size by Country
6.4.1 North America Platelet-rich Plasma Therapy Market Size by Country (2016-2021)
6.4.2 North America Platelet-rich Plasma Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Platelet-rich Plasma Therapy Market Size (2016-2027)
7.2 Europe Platelet-rich Plasma Therapy Market Size by Type
7.2.1 Europe Platelet-rich Plasma Therapy Market Size by Type (2016-2021)
7.2.2 Europe Platelet-rich Plasma Therapy Market Size by Type (2022-2027)
7.2.3 Europe Platelet-rich Plasma Therapy Market Size by Type (2016-2027)
7.3 Europe Platelet-rich Plasma Therapy Market Size by Application
7.3.1 Europe Platelet-rich Plasma Therapy Market Size by Application (2016-2021)
7.3.2 Europe Platelet-rich Plasma Therapy Market Size by Application (2022-2027)
7.3.3 Europe Platelet-rich Plasma Therapy Market Size by Application (2016-2027)
7.4 Europe Platelet-rich Plasma Therapy Market Size by Country
7.4.1 Europe Platelet-rich Plasma Therapy Market Size by Country (2016-2021)
7.4.2 Europe Platelet-rich Plasma Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size (2016-2027)
8.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type
8.2.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application
8.3.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region
8.4.1 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Platelet-rich Plasma Therapy Market Size (2016-2027)
9.2 Latin America Platelet-rich Plasma Therapy Market Size by Type
9.2.1 Latin America Platelet-rich Plasma Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Platelet-rich Plasma Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Platelet-rich Plasma Therapy Market Size by Type (2016-2027)
9.3 Latin America Platelet-rich Plasma Therapy Market Size by Application
9.3.1 Latin America Platelet-rich Plasma Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Platelet-rich Plasma Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Platelet-rich Plasma Therapy Market Size by Application (2016-2027)
9.4 Latin America Platelet-rich Plasma Therapy Market Size by Country
9.4.1 Latin America Platelet-rich Plasma Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Platelet-rich Plasma Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size (2016-2027)
10.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type
10.2.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application
10.3.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country
10.4.1 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Terumo
11.1.1 Terumo Company Details
11.1.2 Terumo Business Overview
11.1.3 Terumo Platelet-rich Plasma Therapy Introduction
11.1.4 Terumo Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.1.5 Terumo Recent Development
11.2 Arthrex
11.2.1 Arthrex Company Details
11.2.2 Arthrex Business Overview
11.2.3 Arthrex Platelet-rich Plasma Therapy Introduction
11.2.4 Arthrex Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.2.5 Arthrex Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Platelet-rich Plasma Therapy Introduction
11.3.4 Zimmer Biomet Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.3.5 Zimmer Biomet Recent Development
11.4 DePuy Synthes
11.4.1 DePuy Synthes Company Details
11.4.2 DePuy Synthes Business Overview
11.4.3 DePuy Synthes Platelet-rich Plasma Therapy Introduction
11.4.4 DePuy Synthes Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.4.5 DePuy Synthes Recent Development
11.5 EmCyte
11.5.1 EmCyte Company Details
11.5.2 EmCyte Business Overview
11.5.3 EmCyte Platelet-rich Plasma Therapy Introduction
11.5.4 EmCyte Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.5.5 EmCyte Recent Development
11.6 Regen Lab
11.6.1 Regen Lab Company Details
11.6.2 Regen Lab Business Overview
11.6.3 Regen Lab Platelet-rich Plasma Therapy Introduction
11.6.4 Regen Lab Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.6.5 Regen Lab Recent Development
11.7 ISTO Biologics
11.7.1 ISTO Biologics Company Details
11.7.2 ISTO Biologics Business Overview
11.7.3 ISTO Biologics Platelet-rich Plasma Therapy Introduction
11.7.4 ISTO Biologics Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.7.5 ISTO Biologics Recent Development
11.8 Cesca Therapeutics
11.8.1 Cesca Therapeutics Company Details
11.8.2 Cesca Therapeutics Business Overview
11.8.3 Cesca Therapeutics Platelet-rich Plasma Therapy Introduction
11.8.4 Cesca Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.8.5 Cesca Therapeutics Recent Development
11.9 Weigao
11.9.1 Weigao Company Details
11.9.2 Weigao Business Overview
11.9.3 Weigao Platelet-rich Plasma Therapy Introduction
11.9.4 Weigao Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.9.5 Weigao Recent Development
11.10 REV-MED
11.10.1 REV-MED Company Details
11.10.2 REV-MED Business Overview
11.10.3 REV-MED Platelet-rich Plasma Therapy Introduction
11.10.4 REV-MED Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.10.5 REV-MED Recent Development
11.11 Nuo Therapeutics
11.11.1 Nuo Therapeutics Company Details
11.11.2 Nuo Therapeutics Business Overview
11.11.3 Nuo Therapeutics Platelet-rich Plasma Therapy Introduction
11.11.4 Nuo Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2016-2021)
11.11.5 Nuo Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Platelet-rich Plasma Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pure PRP
Table 3. Key Players of Leucocyte-rich PRP
Table 4. Key Players of Leukocyte-rich Fibrin (L-PRF)
Table 5. Global Platelet-rich Plasma Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Platelet-rich Plasma Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Platelet-rich Plasma Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Platelet-rich Plasma Therapy Market Share by Regions (2016-2021)
Table 9. Global Platelet-rich Plasma Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Platelet-rich Plasma Therapy Market Share by Regions (2022-2027)
Table 11. Platelet-rich Plasma Therapy Market Trends
Table 12. Platelet-rich Plasma Therapy Market Drivers
Table 13. Platelet-rich Plasma Therapy Market Challenges
Table 14. Platelet-rich Plasma Therapy Market Restraints
Table 15. Global Platelet-rich Plasma Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Platelet-rich Plasma Therapy Market Share by Players (2016-2021)
Table 17. Global Top Platelet-rich Plasma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platelet-rich Plasma Therapy as of 2020)
Table 18. Ranking of Global Top Platelet-rich Plasma Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Platelet-rich Plasma Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Platelet-rich Plasma Therapy Product Solution and Service
Table 22. Date of Enter into Platelet-rich Plasma Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Platelet-rich Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Platelet-rich Plasma Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Platelet-rich Plasma Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Platelet-rich Plasma Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Platelet-rich Plasma Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Platelet-rich Plasma Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Platelet-rich Plasma Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Platelet-rich Plasma Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Platelet-rich Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Platelet-rich Plasma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Platelet-rich Plasma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Platelet-rich Plasma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Platelet-rich Plasma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Platelet-rich Plasma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Platelet-rich Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Platelet-rich Plasma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Platelet-rich Plasma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Platelet-rich Plasma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Platelet-rich Plasma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Platelet-rich Plasma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Platelet-rich Plasma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Platelet-rich Plasma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Platelet-rich Plasma Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Platelet-rich Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Platelet-rich Plasma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Platelet-rich Plasma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Platelet-rich Plasma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Platelet-rich Plasma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Platelet-rich Plasma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Platelet-rich Plasma Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Platelet-rich Plasma Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Platelet-rich Plasma Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Terumo Company Details
Table 63. Terumo Business Overview
Table 64. Terumo Platelet-rich Plasma Therapy Product
Table 65. Terumo Revenue in Platelet-rich Plasma Therapy Business (2016-2021) & (US$ Million)
Table 66. Terumo Recent Development
Table 67. Arthrex Company Details
Table 68. Arthrex Business Overview
Table 69. Arthrex Platelet-rich Plasma Therapy Product
Table 70. Arthrex Revenue in Platelet-rich Plasma Therapy Business (2016-2021) & (US$ Million)
Table 71. Arthrex Recent Development
Table 72. Zimmer Biomet Company Details
Table 73. Zimmer Biomet Business Overview
Table 74. Zimmer Biomet Platelet-rich Plasma Therapy Product
Table 75. Zimmer Biomet Revenue in Platelet-rich Plasma Therapy Business (2016-2021) & (US$ Million)
Table 76. Zimmer Biomet Recent Development
Table 77. DePuy Synthes Company Details
Table 78. DePuy Synthes Business Overview
Table 79. DePuy Synthes Platelet-rich Plasma Therapy Product
Table 80. DePuy Synthes Revenue in Platelet-rich Plasma Therapy Business (2016-2021) & (US$ Million)
Table 81. DePuy Synthes Recent Development
Table 82. EmCyte Company Details
Table 83. EmCyte Business Overview
Table 84. EmCyte Platelet-rich Plasma Therapy Product
Table 85. EmCyte Revenue in Platelet-rich Plasma Therapy Business (2016-2021) & (US$ Million)
Table 86. EmCyte Recent Development
Table 87. Regen Lab Company Details
Table 88. Regen Lab Business Overview
Table 89. Regen Lab Platelet-rich Plasma Therapy Product
Table 90. Regen Lab Revenue in Platelet-rich Plasma Therapy Business (2016-2021) & (US$ Million)
Table 91. Regen Lab Recent Development
Table 92. ISTO Biologics Company Details
Table 93. ISTO Biologics Business Overview
Table 94. ISTO Biologics Platelet-rich Plasma Therapy Product
Table 95. ISTO Biologics Revenue in Platelet-rich Plasma Therapy Business (2016-2021) & (US$ Million)
Table 96. ISTO Biologics Recent Development
Table 97. Cesca Therapeutics Company Details
Table 98. Cesca Therapeutics Business Overview
Table 99. Cesca Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2016-2021) & (US$ Million)
Table 100. Cesca Therapeutics Recent Development
Table 101. Weigao Company Details
Table 102. Weigao Business Overview
Table 103. Weigao Platelet-rich Plasma Therapy Product
Table 104. Weigao Revenue in Platelet-rich Plasma Therapy Business (2016-2021) & (US$ Million)
Table 105. Weigao Recent Development
Table 106. REV-MED Company Details
Table 107. REV-MED Business Overview
Table 108. REV-MED Platelet-rich Plasma Therapy Product
Table 109. REV-MED Revenue in Platelet-rich Plasma Therapy Business (2016-2021) & (US$ Million)
Table 110. REV-MED Recent Development
Table 111. Nuo Therapeutics Company Details
Table 112. Nuo Therapeutics Business Overview
Table 113. Nuo Therapeutics Platelet-rich Plasma Therapy Product
Table 114. Nuo Therapeutics Revenue in Platelet-rich Plasma Therapy Business (2016-2021) & (US$ Million)
Table 115. Nuo Therapeutics Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Platelet-rich Plasma Therapy Market Share by Type: 2020 VS 2027
Figure 2. Pure PRP Features
Figure 3. Leucocyte-rich PRP Features
Figure 4. Leukocyte-rich Fibrin (L-PRF) Features
Figure 5. Global Platelet-rich Plasma Therapy Market Share by Application: 2020 VS 2027
Figure 6. Orthopedic Case Studies
Figure 7. Darmatology Case Studies
Figure 8. Cardiac Muscle Injury Case Studies
Figure 9. Dental Case Studies
Figure 10. Nerve Injury Case Studies
Figure 11. Others Case Studies
Figure 12. Platelet-rich Plasma Therapy Report Years Considered
Figure 13. Global Platelet-rich Plasma Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Platelet-rich Plasma Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Platelet-rich Plasma Therapy Market Share by Regions: 2020 VS 2027
Figure 16. Global Platelet-rich Plasma Therapy Market Share by Regions (2022-2027)
Figure 17. Global Platelet-rich Plasma Therapy Market Share by Players in 2020
Figure 18. Global Top Platelet-rich Plasma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platelet-rich Plasma Therapy as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Platelet-rich Plasma Therapy Revenue in 2020
Figure 20. Global Platelet-rich Plasma Therapy Revenue Market Share by Type (2016-2021)
Figure 21. Global Platelet-rich Plasma Therapy Revenue Market Share by Type (2022-2027)
Figure 22. North America Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Platelet-rich Plasma Therapy Market Share by Type (2016-2027)
Figure 24. North America Platelet-rich Plasma Therapy Market Share by Application (2016-2027)
Figure 25. North America Platelet-rich Plasma Therapy Market Share by Country (2016-2027)
Figure 26. United States Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Platelet-rich Plasma Therapy Market Share by Type (2016-2027)
Figure 30. Europe Platelet-rich Plasma Therapy Market Share by Application (2016-2027)
Figure 31. Europe Platelet-rich Plasma Therapy Market Share by Country (2016-2027)
Figure 32. Germany Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Platelet-rich Plasma Therapy Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Platelet-rich Plasma Therapy Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Platelet-rich Plasma Therapy Market Share by Region (2016-2027)
Figure 42. China Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Platelet-rich Plasma Therapy Market Share by Type (2016-2027)
Figure 50. Latin America Platelet-rich Plasma Therapy Market Share by Application (2016-2027)
Figure 51. Latin America Platelet-rich Plasma Therapy Market Share by Country (2016-2027)
Figure 52. Mexico Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Platelet-rich Plasma Therapy Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Platelet-rich Plasma Therapy Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Platelet-rich Plasma Therapy Market Share by Country (2016-2027)
Figure 58. Turkey Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Platelet-rich Plasma Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Terumo Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2016-2021)
Figure 62. Arthrex Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2016-2021)
Figure 63. Zimmer Biomet Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2016-2021)
Figure 64. DePuy Synthes Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2016-2021)
Figure 65. EmCyte Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2016-2021)
Figure 66. Regen Lab Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2016-2021)
Figure 67. ISTO Biologics Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2016-2021)
Figure 68. Cesca Therapeutics Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2016-2021)
Figure 69. Weigao Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2016-2021)
Figure 70. REV-MED Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2016-2021)
Figure 71. Nuo Therapeutics Revenue Growth Rate in Platelet-rich Plasma Therapy Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介
  • 世界の多血小板血漿治療市場規模・現状・予測（2021年-2027年）
    Global Platelet Rich Plasma Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-5307 2021年6月 99Pages
    QYResearch社発行の本調査レポートでは、多血小板血漿治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（P-PRP、L-PRF、L-PRP）、用途別市場規模（整形外科手術、美容整形、一般手術、その他手術）、主要地域別市場規模（北米、アメリカ...
  • 世界の脱毛症幹細胞＆多血小板血漿（PRP）治療市場規模・現状・予測（2021年-2027年）
    Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size, Status and Forecast 2021-2027
    QFJ1-6020 2021年6月 100Pages
    QYResearch社発行の本調査レポートでは、脱毛症幹細胞＆多血小板血漿（PRP）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（多血小板血漿注射、幹細胞治療）、用途別市場規模（皮膚科クリニック、病院）、主要地域別市場規模（北米、アメリカ、欧...
  • 多血小板血漿療法のグローバル市場：規模・現状・予測2019-2025
    Global Platelet-rich Plasma Therapy Market Size, Status and Forecast 2019-2025
    QYR9NV18295 2019年11月18日 97Pages
    ※当調査レポートでは、多血小板血漿療法の世界市場について調査・分析し、多血小板血漿療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（純粋なPRP、白血球が豊富なPRP、白血球が豊富なフィブリン（L...
  • 多血小板血漿療法のグローバル市場：規模・現状・予測2019-2025
    Global Platelet-rich Plasma Therapy Market Size, Status and Forecast 2019-2025
    QYR9NV18295 2019年11月18日 97Pages
    ※当調査レポートでは、多血小板血漿療法の世界市場について調査・分析し、多血小板血漿療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（純粋なPRP、白血球が豊富なPRP、白血球が豊富なフィブリン（L...
  • 世界の自己調整血漿療法市場規模・現状・予測（2021年-2027年）
    Global Autologous Conditioned Plasma Therapy Market Size, Status and Forecast 2021-2027
    QFJ1-3874 2021年6月 108Pages
    QYResearch社発行の本調査レポートでは、自己調整血漿療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（純粋多血小板血漿(P-PRP)、白血球・多血小板血漿(LPRP)、純粋多血小板血漿フィブリン(P-PRF)、白血球・多血小板血漿フィブリ...
  • 世界の重粒子線治療市場規模・現状・予測（2021年-2027年）
    Global Heavy Ion Therapy Market Size, Status and Forecast 2021-2027
    QFJ1-5188 2021年6月 88Pages
    QYResearch社発行の本調査レポートでは、重粒子線治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、サービス）、用途別市場規模（科学研究所、医療、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...
  • 世界の組換え血漿タンパク質市場規模・現状・予測（2021年-2027年）
    Global Recombinant Plasma Proteins Market Size, Status and Forecast 2021-2027
    QFJ1-4799 2021年6月 96Pages
    QYResearch社発行の本調査レポートでは、組換え血漿タンパク質の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（チャイニーズハムスター卵巣（CHO）細胞株、ベイビーハムスター腎臓（BHK）細胞株、ヒト胎児腎臓（HEK）細胞株、その他）、用途別市...
  • 世界の血漿由来人血清アルブミン検査市場規模・現状・予測（2021年-2027年）
    Global Plasma-derived Human Serum Albumin Test Market Size, Status and Forecast 2021-2027
    QFJ1-4717 2021年6月 108Pages
    QYResearch社発行の本調査レポートでは、血漿由来人血清アルブミン検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、消耗品、その他）、用途別市場規模（病院・クリニック、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...
  • 世界の迅速血漿レアギン検査市場規模・現状・予測（2021年-2027年）
    Global Rapid Plasma Reagin Test Market Size, Status and Forecast 2021-2027
    QFJ1-4794 2021年6月 108Pages
    QYResearch社発行の本調査レポートでは、迅速血漿レアギン検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体検査、蛍光抗体検査、蛍光トレポネマ抗体吸収検査、トリポネーマ・パリダム血球凝集反応アッセイ）、用途別市場規模（病院...
  • 世界の血漿誘導体市場規模・現状・予測（2021年-2027年）
    Global Blood Plasma Derivatives Market Size, Status and Forecast 2021-2027
    QFJ1-5628 2021年6月 124Pages
    QYResearch社発行の本調査レポートでは、血漿誘導体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルブミン、ファクターVIII、ファクターIX、イムノグロブリン、ハイパーイムンググロブリン、その他）、用途別市場規模（病院、診療所、その他）...